Structure Therapeutics (GPCR) Institutional Ownership

91.78% of Structure Therapeutics' stock is owned by institutional investors. Learn more on GPCR's institutional investor holdings.

Of the 203 institutional investors that purchased Structure Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Principal Financial Group Inc. ($1.76M), Janus Henderson Group PLC ($1.71M), Wellington Management Group LLP ($1.68M), Deep Track Capital LP ($1.58M), Morgan Stanley ($1.51M), Price T Rowe Associates Inc. MD ($1.38M), and Vestal Point Capital LP ($1.26M).

Institutional investors have bought a total of 19,502,103 shares in the last 24 months. This purchase volume represents approximately $1.08B in transactions.

Of the 75 institutional investors that sold Structure Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($1.19M), Federated Hermes Inc. ($1.17M), Millennium Management LLC ($1.12M), Baker BROS. Advisors LP ($1.08M), Deep Track Capital LP ($918.11K), Vestal Point Capital LP ($588.99K), and Invesco Ltd. ($440.54K).

Institutional investors have sold a total of 12,043,208 shares in the last 24 months. This volume of shares sold represents approximately $531.02M in transactions.